Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2005
07/26/2005CA2174632C Methods of screening for beta-amyloid peptide production inhibitors
07/26/2005CA2173611C Method of treating depressed reticuloendothelial system function
07/26/2005CA2143823C Retro-, inverso - and retro-inverso synthetic peptide analogues
07/26/2005CA2005567C Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system
07/22/2005CA2455659A1 Barhl2 proteins, genes encoding the same and uses thereof
07/21/2005WO2005066867A2 Modulators of cell-surface receptors of the ig-class
07/21/2005WO2005066633A2 Fluorescent ligands for gpcr arrays
07/21/2005WO2005066365A1 Specific expression of ndrg2 gene in dendritic cells and detection of dendritic cells
07/21/2005WO2005066363A2 Cancer specific gene ccndbp1
07/21/2005WO2005066349A2 Genes encoding proteins with pesticidal activity
07/21/2005WO2005066348A2 Interleukin-12 targeted to oncofoetal fibronectin
07/21/2005WO2005066345A1 Diabetogenic epitopes
07/21/2005WO2005066344A2 New plasmids, their derivatives and fragments, their methods of manufacture and application
07/21/2005WO2005066339A2 Polypeptides of alicyclobacillus sp.
07/21/2005WO2005066211A2 Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention
07/21/2005WO2005066209A1 Nucleic acid encoding a novel prostaglandin receptor protein and methods of use thereof
07/21/2005WO2005066208A2 Method for production of recombinant growth hormone in form of hybrid protein
07/21/2005WO2005066207A1 Glucagon-like peptide-1 analogs with long duration of action
07/21/2005WO2005066206A1 Tnf antagonists and tnf inhibitors comprising the same as the active ingredient
07/21/2005WO2005066205A2 Antiviral compositions which inhibit paramyxovirus infection
07/21/2005WO2005066204A2 Neutralizing epitope-based growth enhancing vaccine
07/21/2005WO2005066203A2 Targeted immunogens
07/21/2005WO2005066202A2 Bacillus cry9 family members
07/21/2005WO2005066201A1 Amino acid sequences from active principle of musk and their acetic salt, also the preparation and usage
07/21/2005WO2005066200A1 Novel peptide, process for producing the same and pharmaceutical composition containing the peptide
07/21/2005WO2005065722A2 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation
07/21/2005WO2005065720A1 Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same
07/21/2005WO2005065711A2 Mammalian receptor proteins; related reagents and methods
07/21/2005WO2005065707A2 Recombinant vaccine against japanese encephalitis virus [jev] infection and a method thereof
07/21/2005WO2005065702A1 Novel use of ligand to gpr103-like receptor protein
07/21/2005WO2005065697A1 Method for the photostabilisation of phycobiliproteins in an aqueous extract, compositions containing stabilised phycobiliproteins and use of stabilised phycobiliproteins
07/21/2005WO2005065405A1 Membranes incorporating recognition moieties
07/21/2005WO2005065382A2 Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof
07/21/2005WO2005065339A2 Cell cycle genes and related methods of using
07/21/2005WO2005065309A2 Lentiviral vector delivery of native and mutated igfbp-3 for treatment of cancer
07/21/2005WO2005065268A2 Oligonucleotide compound and method for treating nidovirus infections
07/21/2005WO2005065239A2 Novel recombinant proteins with n-terminal free thiol
07/21/2005WO2005065017A2 Methods of inducing il-10 production
07/21/2005WO2005065015A2 Neutralizing antibodies and methods of use thereof
07/21/2005WO2005051992A8 Use of neublasmin as a maker for testis cancer
07/21/2005WO2005049786A3 Modulation of angiogenesis by bartonella henselae
07/21/2005WO2005047455A3 Methods for the production of apolipoproteins in transgenic plants
07/21/2005WO2005037991A3 Interacts with ice1 and regulates cbf expression and freezing tolerance in arabidopsis
07/21/2005WO2005037226A3 Genetically engineered enteroendocrine cells for treating glucose-related metabolic disorders
07/21/2005WO2005028657A3 Excretable reporter systems
07/21/2005WO2005026316A8 Alphavirus vaccines
07/21/2005WO2005019256A3 Muteins of tear lipocalin
07/21/2005WO2005015990A8 New diabetes type 2 animal model
07/21/2005WO2005014823A3 Targeted carrier fusions for delivery of chemotherapeutic agents
07/21/2005WO2005014630A3 Streptococcus pneumoniae knockout mutants
07/21/2005WO2005012351A3 Novel functions for decay accelerating factor (daf) in inflammation
07/21/2005WO2005011607A3 Treatment of cancers expressing p95 erbb2
07/21/2005WO2005003313A3 Methods and compositions for enhanced protein expression and purification
07/21/2005WO2004099436A3 Structural and cytoskeleton-associated proteins
07/21/2005WO2004090109A3 Ccn3 compositions and methods
07/21/2005WO2004076481A3 Hypoallergenic der p 1 and der p 3 proteins from dermatographoides pteronyssinus
07/21/2005WO2004058944A8 Product quality enhancement in mammalian cell culture processes for protein production
07/21/2005WO2004058169A3 Mag derivatives, compositions, and methods of use thereof
07/21/2005WO2004056866A8 Asthma susceptibility locus
07/21/2005WO2004038371A3 Ccr8 as modifier of branching morphogenesis and methods of use
07/21/2005WO2004029197A8 Co-stimulatory molecules
07/21/2005WO2004024064A8 Compositions and methods for the diagnosis and treatment of tumor
07/21/2005WO2004018648A3 Methods for treating patients and identifying therapeutics
07/21/2005WO2003104438A3 Cancer-linked gene as target for chemotherapy
07/21/2005WO2003085095A3 Novel expressed genes
07/21/2005WO2003078573A8 Toll-like receptor 11
07/21/2005WO2003074005A8 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
07/21/2005US20050160500 Recombinant seeds for propagating drought and freeze resistant crops; early flowering
07/21/2005US20050160499 Vernalization-related molecules and methods for inducibly-conferring epigenetic changes
07/21/2005US20050160493 Yield-related polynucleotides and polypeptides in plants
07/21/2005US20050160491 Transgenic plants compromising nucleic acid molecules encoding RAR1 disease resistance proteins and uses thereof
07/21/2005US20050160488 Grain quality through altered expression of seed proteins
07/21/2005US20050160486 Using g protein coupled receptor to identify modulators for prevention and treatment of urogenital disorders; immunotherapeutics; genetic vaccines
07/21/2005US20050160484 Orphanin FQ receptor polypeptides
07/21/2005US20050160483 Glycosaminoglycan deficient proteoglycan expressed in recombinant goat; antiscarring agents and reconstructive/cosmetic surgery
07/21/2005US20050159901 Three-dimensional model; drug design
07/21/2005US20050159591 Compositions and methods for the diagnosis and treatment of tumor
07/21/2005US20050159590 Variants of interleukin-1 receptor antagonist: compositions and uses thereof
07/21/2005US20050159589 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor
07/21/2005US20050159588 Nucleotide sequences coding tumor-associated antigenic target polypeptides; diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents
07/21/2005US20050159587 Extracellular junctional adhesion molecules
07/21/2005US20050159586 Linear gamma-carboxyglutamate rich conotoxins
07/21/2005US20050159421 Ethylene diamine derivatives and their use as orexin-receptor antagonists
07/21/2005US20050159386 Antitumoral composition based on immunogenic polypeptide with modified cell location
07/21/2005US20050159373 Novel polypeptides, and nucleic acids encoding the same
07/21/2005US20050159362 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
07/21/2005US20050159358 polypeptides, multimeric proteins, and polynucleotides of which are for study and regulation of cell and tissue development
07/21/2005US20050159355 For treatment of inflammatory diseases
07/21/2005US20050159354 Administering agrin fragments which play role in regulating response of central nervous system neurons to excitatory neurotransmitters such as glutamate and nicotine
07/21/2005US20050159352 Use of monocarboxylate transporter protein for thyroid hormone transport
07/21/2005US20050159351 polynucleotides that bind to proteins that regulate cell growth and division; used as antitumor agents alone or in combination with known cytotoxic agents
07/21/2005US20050159350 Has superagonist properties and is used to stimulate cell division and treat wounds, ischemia, heart disease, neural injuries, peripheral vascular disease, gastric ulcers and duodenal ulcers
07/21/2005US20050159349 For treatment of cancer; nontoxic
07/21/2005US20050159348 Methods of treatment of periodontal disease
07/21/2005US20050159345 Such as encephalitis and hepatitis
07/21/2005US20050159343 Inhibitors of glycosaminoglycans
07/21/2005US20050159332 Ntb-a,a a surface molecule involved in natural killer cellss activity
07/21/2005US20050158859 Manipulation of non-terminally differentiated cells using the Notch pathway
07/21/2005US20050158843 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted
07/21/2005US20050158839 comprises an amino acid sequence of a catalytic module having glucoamylase activity and an amino acid sequence of a carbohydrate-binding module; producing syrup or a fermentation product from granular starch comprising subjecting the raw starch to an alpha-amylase and a hybrid enzyme having glucoamylase
1 ... 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 ... 2916